Robin Patel, M.D., Receives NIAMS STAR Award
Robin Patel, M.D., Chair of the Division of Clinical Microbiology and a Consultant in the Clinical Microbiology and Infectious Diseases Research Laboratories at Mayo Clinic, received a Supplements to Advance Research (STAR) award from the NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The STAR awards program provides additional support for early-career-stage investigators. Supplemental funding allows early-established investigators to pursue innovative and high-risk research within the broader scope of a current NIAMS-funded, peer-reviewed research project. The award also helps investigators to expand a single, structured research project into a broader multi-faceted research program.
Dr. Patel’s research program is focused on understanding the pathogenesis of orthopedic infection and developing strategies for their detection and management with an emphasis on prosthetic joint infection.
"Dr. Patel's work in this area spans almost two decades, and she is an internationally recognized expert in this field who has substantially contributed to and shaped the clinical practice of prosthetic joint infection management at Mayo Clinic," said William Morice, II, M.D., Ph.D., Chair of the Department of Laboratory Medicine and Pathology. "Her research program has the opportunity to flourish at our institution because it is an ideal setting for studies of orthopedic infection."
Mayo Clinic’s Department of Orthopedic Surgery includes 88 faculty members and its Division of Infectious Diseases' specialty group, the Orthopedic Infectious Diseases Core Group, is dedicated to the care of patients with orthopedic infection. The Mayo Clinic Clinical Microbiology Laboratory, with its more than 250 staff, performs almost 3,000,000 tests a year and is the largest academic clinical microbiology laboratory in the United States. This laboratory provides rich access to clinical specimens from the large orthopedic practice at Mayo Clinic.
"Dr. Patel’s proposed metagenomics studies perfectly align with the goals of Mayo Clinic’s Center for Individualized Medicine, which seeks to help Mayo Clinic emerge as the global leader in health care that focuses on genomic and molecular interactions at the foundation of disease," added Dr. Morice.